Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Veracyte (VCYT) Misses Q4 EPS by 4c, Revenues Beat; Offers 1Q Revenues Guidance Above Consensus
February 17, 2021 4:29 PM ESTVeracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $31.93 million.
For the three months ended December 31, 2020, compared to the prior year:
Total Revenue was $34.5 million, an increase of 16%;Gross Margin was 68%, an increase of 2 percentage points;Operating Expenses, Excluding Cost of Revenue, were $31.4 million, an increase of... More